Medical Oncology

Doç. Dr. Ferit Aslan

Doctor and researcher Medical Park Ankara (Batıkent) Ankara
Breast NeoplasmsColonic Neoplasms
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Breast Neoplasms 6 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Colonic Neoplasms 2 publications

CV

Education and experience

From source

Education

  • EducationDicle Üniversitesi Tıp Fakültesi - Lisansmedicalpark.com.tr
  • Educationİzmir Katip Çelebi Üniversitesi Atatürk Eğitim ve Araştırma Hastanesi - İç Hastalıkları - Uzmanlıkmedicalpark.com.tr
  • EducationSBÜ Ankara Dr Abdurrahman Yurtarslan Onkoloji Eğitim ve Araştırma Hastanesi - Tıbbi Onkoloji - Yandal Uzmanlıkmedicalpark.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologymedicalpark.com.trFrom source
  • Department name at the sourceMedikal Onkoloji (Tıbbi Onkoloji)medicalpark.com.trFrom source
  • InstitutionMedical Park Ankara (Batıkent)medicalpark.com.trFrom source
  • Area of workBreast NeoplasmsExtracted from 6 publications · Model version —From source
  • Publications94 publicationsOpenAlex, ORCIDFrom source
  • ORCID0000-0002-9153-6921ORCIDFrom source
  • Last synchronised4 November 2026 20:32https://www.medicalpark.com.tr/hekimler/ferit-aslanmedicalpark.com.tr

Scientific work

Publications on Breast Neoplasms

94 publications

  1. Real-world effectiveness of total neoadjuvant therapy in locally advanced rectal cancer: a multicenter retrospective study

    Discover Oncology, 2026

    DOI 10.1007/s12672-026-04842-3 PMID 41870760 Open-access full textSource: OpenAlex

  2. Real-World Treatment Patterns and Survival in Uveal Melanoma: A Multicenter Cohort Study by the Turkish Oncology Group (TOG)

    Cancers, 2026

    DOI 10.3390/cancers18030394 PMID 41681877 1 citation (Europe PMC) Open-access full textSource: ORCID

  3. Electrochemical detection and DNA binding mechanism of alectinib using a green-synthesized CPE/Rc-AuNP sensor supported by spectroscopic and theoretical analyses

    Surfaces and Interfaces, 2026

    DOI 10.1016/j.surfin.2026.110701 Source: ORCID

  4. Association of Cabazitaxel Treatment Beyond 10 Cycles with Survival Outcomes in Metastatic Castration-Resistant Prostate Cancer: A Retrospective 8-Month Landmark Analysis

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15186966 PMID 42795739 Open-access full textSource: ORCID

  5. Clinical Characteristics and Survival Outcomes of a Clinically Defined Treatment-Emergent Neuroendocrine/Aggressive-Variant Prostate Cancer Phenotype: A Retrospective Study

    Medicina, 2026

    DOI 10.3390/medicina62091702 PMID 42796309 Open-access full textSource: ORCID

  6. Real-World Efficacy and Safety of Tyrosine Kinase Inhibitors in Patients With Advanced Bone Sarcomas: The TOGBONE Study of the Turkish Oncology Group

    JCO Global Oncology, 2026

    DOI 10.1200/go-26-00317 PMID 42715501 Open-access full textSource: ORCID

  7. Sustainable carbon electrode-based voltammetric method for sensitive determination of Alectinib, a targeted anti-cancer drug

    Diamond and Related Materials, 2026

    DOI 10.1016/j.diamond.2026.113830 Source: ORCID

  8. Clinical Significance of Achieving No Evidence of Disease in HER2-Positive Metastatic Breast Cancer: A Multicenter Study by Turkish Oncology Group (TOG)

    Cancers, 2026

    DOI 10.3390/cancers18060915 PMID 41899520 1 citation (Europe PMC) Open-access full textSource: ORCID

  9. Synchronous Adrenocortical Carcinoma, Renal Cell Carcinoma, and Mediastinal Mature Teratoma with Heterozygous Variants in SMARCA4, APC, and MYBP3: A Case Report

    Journal of Oncological Sciences, 2026

    DOI 10.37047/jos.galenos.2026.2025-10-7 Open-access full textSource: ORCID

  10. Level II (IIA/IIB) Lymph Node Evaluation in Head and Neck Cancer: A Retrospective Cohort Study from a Non-Endemic Region

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15031068 PMID 41682748 Open-access full textSource: ORCID

View all 94 publications